These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 7856283

  • 1. [Indications for ACE inhibitors in the postinfarct period].
    Ertl G, Gaudron P, Neubauer S, Hu K, Zdrojewski T, Horn M, Kochsiek K.
    Z Kardiol; 1994; 83 Suppl 4():65-74. PubMed ID: 7856283
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
    Young JB.
    Cardiol Clin; 1995 Aug; 13(3):379-90. PubMed ID: 7585774
    [Abstract] [Full Text] [Related]

  • 4. [ACE inhibitors and angiotensin II receptor antagonists in acute coronary syndrome].
    Milicić D.
    Acta Med Croatica; 2004 Aug; 58(2):129-34. PubMed ID: 15208798
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [New aspects of ACE inhibitor treatment of heart failure].
    Dietz R, Osterziel KJ.
    Z Kardiol; 1996 Aug; 85 Suppl 6():241-6. PubMed ID: 9064971
    [Abstract] [Full Text] [Related]

  • 9. [Current aspects of ACE inhibitor therapy from the cardiologic viewpoint].
    Klein W, Eber B, Gasser R, Stoschitzky K, Schumacher M, Fruhwald FM, Zweiker R.
    Wien Med Wochenschr; 1996 Aug; 146(11):221-4. PubMed ID: 8928518
    [Abstract] [Full Text] [Related]

  • 10. The Survival and Ventricular Enlargement (SAVE) study: rationale and perspective.
    Pfeffer MA.
    Herz; 1993 Dec; 18 Suppl 1():430-5. PubMed ID: 8125423
    [Abstract] [Full Text] [Related]

  • 11. Ventricular remodeling and its prevention in the treatment of heart failure.
    Patten RD, Udelson JE, Konstam MA.
    Curr Opin Cardiol; 1998 May; 13(3):162-7. PubMed ID: 9649938
    [Abstract] [Full Text] [Related]

  • 12. Therapy of left ventricular dysfunction: implications of recent therapeutic trials and future directions for therapy.
    Pitt B.
    Schweiz Med Wochenschr; 1993 Feb 27; 123(8):342-8. PubMed ID: 8095738
    [Abstract] [Full Text] [Related]

  • 13. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G, Nicolosi GL, Chiariello M, Ferrari R, Remme P, Tavazzi L.
    Ital Heart J; 2005 Nov 27; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [Abstract] [Full Text] [Related]

  • 14. What have the ACE-inhibitor trials in postmyocardial patients with left ventricular dysfunction taught us?
    Reynolds G, Hall AS, Ball SG.
    Eur J Clin Pharmacol; 1996 Nov 27; 49 Suppl 1():S35-9. PubMed ID: 8834930
    [Abstract] [Full Text] [Related]

  • 15. [ACE inhibitors in the treatment of patients after myocardial infarct].
    Widimský J.
    Vnitr Lek; 1993 Jun 27; 39(6):527-35. PubMed ID: 8212605
    [Abstract] [Full Text] [Related]

  • 16. [ACE-inhibitors in acute heart infarct].
    Genoni M, Garzoli G, Pfister M, Siegrist P, Malacrida R, Maggioni A, Moccetti T.
    Praxis (Bern 1994); 1996 Apr 23; 85(17):548-53. PubMed ID: 8668893
    [Abstract] [Full Text] [Related]

  • 17. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
    Ferrari R, Papa K, Bernocchi P, Gimbatti OJ, Golcea SS, Bettini A, Ceconi C.
    Ital Heart J; 2005 Nov 23; 6 Suppl 7():24S-32S. PubMed ID: 16485514
    [Abstract] [Full Text] [Related]

  • 18. [Prevention of postinfarction cardiac insufficiency: role of angiotensin converting enzyme inhibitors].
    Guéret P, Cohen-Solal A, Bensaid J.
    Arch Mal Coeur Vaiss; 1992 Nov 23; 85(11 Suppl):1709-16. PubMed ID: 1304144
    [Abstract] [Full Text] [Related]

  • 19. [Treatment by angiotensin converting enzyme inhibitors after myocardial infarction. What did the clinical trials teach us?].
    Guéret P, Garot J, Barnier P.
    Arch Mal Coeur Vaiss; 1996 Aug 23; 89 Spec No 3():33-8. PubMed ID: 8949316
    [Abstract] [Full Text] [Related]

  • 20. Reduction of ischemic events with angiotensin-converting enzyme inhibitors: lessons and controversy emerging from recent clinical trials.
    Young JB.
    Cardiovasc Drugs Ther; 1995 Feb 23; 9(1):89-102. PubMed ID: 7786840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.